RETINAL DYSTROPHY
Clinical trials for RETINAL DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new RETINAL DYSTROPHY trials appear
Sign up with your email to follow new studies for RETINAL DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug metformin could slow blindness in rare eye disease
Disease control Recruiting nowThis study tests whether the diabetes drug metformin is safe and can slow vision loss in people with ABCA4 retinopathy (Stargardt disease), a genetic condition that causes progressive blindness. About 56 participants aged 12 and older will take metformin daily for 24 months, with…
Matched conditions: RETINAL DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: National Eye Institute (NEI) • Aim: Disease control
Last updated May 17, 2026 08:36 UTC
-
Gene therapy injection offers hope for rare childhood blindness
Disease control Recruiting nowThis early-phase study tests a gene therapy called LX107 for people with a rare inherited eye disease that causes vision loss. The treatment is given as an injection under the retina and aims to improve vision and slow disease progression. The study will enroll 13 adults and chil…
Matched conditions: RETINAL DYSTROPHY
Phase: EARLY_PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 04, 2026 16:18 UTC